Huang L, Zhong Y, Chen Q, He D, Zheng G, Yang Y
Cancer Biol Ther. 2024; 25(1):2403205.
PMID: 39295128
PMC: 11649219.
DOI: 10.1080/15384047.2024.2403205.
Eskelinen V, Nivakoski E, Launonen K, Partanen A, Kakko S, Kuusisto M
Hematol Rep. 2024; 16(3):529-540.
PMID: 39189247
PMC: 11348108.
DOI: 10.3390/hematolrep16030051.
Avhad T, Bhangde S
J Orthop Case Rep. 2024; 14(8):174-178.
PMID: 39157502
PMC: 11327678.
DOI: 10.13107/jocr.2024.v14.i08.4690.
Hershkovich O, Sakhnini M, Barkay G, Liberman B, Friedlander A, Lotan R
BMC Cancer. 2024; 24(1):917.
PMID: 39080587
PMC: 11290202.
DOI: 10.1186/s12885-024-12681-0.
Johansson P, Lind Kristjansdottir H, Johansson H, Mellstrom D, Lewerin C
Osteoporos Int. 2024; 35(10):1831-1838.
PMID: 38976026
PMC: 11427511.
DOI: 10.1007/s00198-024-07171-9.
Prevalence, Outcomes and Impact of Disease-Related Complications in the Survival of Multiple Myeloma Patients.
Tothong W, Tantiworawit A, Norasetthada L, Chai-Adisaksopha C, Punnachet T, Hantrakun N
Hematol Rep. 2024; 16(1):89-97.
PMID: 38534879
PMC: 10969878.
DOI: 10.3390/hematolrep16010009.
A review on gold nanoparticles as an innovative therapeutic cue in bone tissue engineering: Prospects and future clinical applications.
Yang D, Nah H, Lee D, Min S, Park S, An S
Mater Today Bio. 2024; 26:101016.
PMID: 38516171
PMC: 10952045.
DOI: 10.1016/j.mtbio.2024.101016.
Efficacy and risk of osteonecrosis of the jaw for pamidronate, zoledronic acid, and denosumab in comparison to alendronate in multiple myeloma patients.
Browne M, Miles B, Mackey J
Proc (Bayl Univ Med Cent). 2024; 37(2):227-229.
PMID: 38343457
PMC: 10857533.
DOI: 10.1080/08998280.2023.2298667.
Zinc Oxide Nanoparticles Trigger Autophagy in the Human Multiple Myeloma Cell Line RPMI8226: an In Vitro Study.
Li Z, Yin X, Lyu C, Wang J, Liu K, Cui S
Biol Trace Elem Res. 2023; 202(3):913-926.
PMID: 37432567
DOI: 10.1007/s12011-023-03737-6.
Management of Multiple Myeloma: A Review for General Practitioners in Oncology.
Monteith B, Sandhu I, Lee A
Curr Oncol. 2023; 30(5):4382-4401.
PMID: 37232792
PMC: 10217377.
DOI: 10.3390/curroncol30050334.
Total Hip Arthroplasty With Prophylactic Fixation of Greater Trochanter and Distal Femur in a Patient With a History of Multiple Myeloma and Breast Cancer.
Small T, Fox K, Edge L, Harker J
Cureus. 2023; 15(4):e37971.
PMID: 37223142
PMC: 10202678.
DOI: 10.7759/cureus.37971.
The incidence of vertebral compression fractures and spinal instability in newly diagnosed multiple myeloma patients.
Zijlstra H, Wolterbeek N, Ponds N, Koene H, Terpstra W, Delawi D
J Orthop. 2023; 38:62-67.
PMID: 36974337
PMC: 10038922.
DOI: 10.1016/j.jor.2023.03.008.
Prescribing Exercise to Cancer Patients Suffering from Increased Bone Fracture Risk Due to Metastatic Bone Disease or Multiple Myeloma in Austria-An Inter- and Multidisciplinary Evaluation Measure.
Crevenna R, Hasenoehrl T, Wiltschke C, Kainberger F, Keilani M
Cancers (Basel). 2023; 15(4).
PMID: 36831587
PMC: 9954683.
DOI: 10.3390/cancers15041245.
Roadmap for new practitioners to navigate the multiple myeloma landscape.
Tam T, Smith E, Lozoya E, Heers H, Andrew Allred P
Heliyon. 2022; 8(9):e10586.
PMID: 36164513
PMC: 9508512.
DOI: 10.1016/j.heliyon.2022.e10586.
Vertebroplasty in patients with multiple myeloma with vertebral compression fractures: protocol for a single-blind randomised controlled trial.
Wickstroem L, Carreon L, Lund T, Abildgaard N, Lorenzen M, Andersen M
BMJ Open. 2021; 11(9):e045854.
PMID: 34489267
PMC: 8422322.
DOI: 10.1136/bmjopen-2020-045854.
Animal Models of Multiple Myeloma Bone Disease.
Mehdi S, Nafees S, Mehdi S, Morris C, Mashouri L, Yoon D
Front Genet. 2021; 12:640954.
PMID: 34163520
PMC: 8215650.
DOI: 10.3389/fgene.2021.640954.
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G, Bjorkholm M, Turesson I, Hultcrantz M, Diamond B, Porwit A
Eur J Haematol. 2021; 107(2):275-282.
PMID: 33966293
PMC: 11036135.
DOI: 10.1111/ejh.13650.
An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix.
Ziouti F, Prates Soares A, Moreno-Jimenez I, Rack A, Bogen B, Cipitria A
J Oncol. 2020; 2020:3985315.
PMID: 32684931
PMC: 7336213.
DOI: 10.1155/2020/3985315.
Targeting anti-cancer agents to bone using bisphosphonates.
Xing L, Ebetino F, Boeckman Jr R, Srinivasan V, Tao J, Sawyer T
Bone. 2020; 138:115492.
PMID: 32585321
PMC: 8485333.
DOI: 10.1016/j.bone.2020.115492.
Prevention of bone disease and early detection of impending fractures in multiple myeloma patients can reduce morbidity and mortality: the necessity of interdisciplinary state-of-the-art treatment.
Herget G, Wasch R, Klein L, Schmal H, Terpos E, Engelhardt M
Haematologica. 2020; 105(4):859-861.
PMID: 32238466
PMC: 7109744.
DOI: 10.3324/haematol.2019.245423.